Waddell & Reed

Fund Detail

Ivy European Opportunities Fund
Class A Shares

Please select a fund and share class

Fund Facts
Ticker Symbol IEOAX
CUSIP 465898815
Fund Code 614
Fund Type Global/International
Fund Inception 5/4/1999
Class Inception 5/4/1999
Fiscal Year End March
Dividends Paid December
Fund Assets (as of 6/30/2014) $210.1 mil
Total Equity Holdings (as of 6/30/2014) 82
Total Holdings (as of 6/30/2014) 84
Portfolio Turnover Rate (as of 3/31/2014) 116%
Lipper Category European Region Funds
Morningstar Category Europe Stock
Benchmarks MSCI Europe NR USD
Daily Prices
as of 7/31/2014
Net Asset Value (NAV) $28.92
NAV Change ($) ($0.60)
NAV Change (%) -2.03%
Weekly NAV Change ($) ($0.87)
Weekly NAV Change (%) -2.92%
Public Offering Price (POP) $30.68
Historical Prices & Distributions
Please select a date
Fund Description
Fund Objective
To seek to provide growth of capital.

Investment Approach
Ivy European Opportunities Fund invests, under normal circumstances, at least 80% of its net assets in the equity securities of European companies. While the Fund tends to favor securities issued by large capitalization European companies, it may invest in securities issued by European companies of any size that provide investment opportunities.
Morningstar Style Box
Source: Morningstar
Returns and Expenses

Data quoted is past performance and current performance may be lower or higher. Past performance is no guarantee of future results. Investment return and principal value of an investment will fluctuate, and shares, when redeemed, may be worth more or less than their original cost.

Performance at NAV does not include the effect of sales charges. Class A shares, including sales charges, reflects the maximum applicable front-end sales load.

Monthly Rates of Return Average Annual Total Returns
as of 7/31/2014
  YTD 1yr 3yr 5yr 10yr Life
Fund at NAV -2.53% 11.63% 6.11% 8.59% 6.03% 14.13%
Fund with 5.75% sales charge -8.13% 5.23% 4.04% 7.31% 5.40% 13.69%
Quarterly Rates of Return Average Annual Total Returns
as of 6/30/2014
  YTD 1yr 3yr 5yr 10yr Life
Fund at NAV 2.06% 24.04% 6.82% 11.32% 5.96% 14.57%
Fund with 5.75% sales charge -3.81% 16.92% 4.73% 10.01% 5.34% 14.12%
MSCI Europe NR USD 5.48% 29.28% 8.67% 13.03% 7.54% 4.74%
Lipper European Region Funds 3.77% 26.77% 9.10% 13.63% 8.18% N/A
Expense Ratios
as of 7/31/2013
Net 1.81%
Gross 1.81%
Growth of a $10,000 Investment
through 7/31/2014

Assumes an investment over 10 years or life of the share class, reinvestment of dividends and capital gains, and does not include the effect of sales charges or taxes.

Ratings and Rankings
Lipper Rankings
as of 6/30/2014
Category: European Region Funds
  Rank Percentile
1 Year 75 / 122 61
3 Year 79 / 96 82
5 Year 64 / 83 77
10 Year 57 / 68 83

Rankings are based on average annual total returns, but do not consider sales charges.

Morningstar Ratings
as of 6/30/2014
Category: Europe Stock
Overall (out of 88 Europe Stock)
3 Year (out of 88 Europe Stock)
5 Year (out of 79 Europe Stock)
10 Year (out of 64 Europe Stock)

Ratings are based on risk-adjusted returns.

Holdings
Portfolio Composition
(as a % of net assets as of 6/30/2014)
Foreign Common Stock 94.52%
Domestic Common Stock 4.59%
Cash and Cash Equivalents 0.89%
Sector Allocation
(as a % of equity holdings as of 6/30/2014)
Health Care 18.9%
Financials 18.4%
Consumer Discretionary 15.1%
Industrials 11.5%
Consumer Staples 10.9%
Energy 10.0%
Materials 5.3%
Information Technology 4.7%
Telecommunication Services 3.7%
Utilities 1.6%
Country Allocation
(as a % of equity holdings as of 6/30/2014)
United Kingdom 38.3%
France 17.0%
Germany 9.0%
Switzerland 7.3%
Netherlands 4.8%
United States 4.6%
Denmark 4.3%
Norway 4.2%
Spain 2.5%
Bermuda 2.3%
Ireland 2.2%
Italy 2.0%
Sweden 1.0%
Canada 0.5%
Top 10 Equity Holdings
(as a % of net assets as of 6/30/2014)
Shire plc, a biopharmaceutical company, researches, develops, manufactures, sells, and distributes pharmaceutical products. It operates in three segments: Specialty Pharmaceuticals, Human Genetic Therapies and Regenerative Medicine.Shire plc 3.7%
[Note: AXA Group is what yahoo points to] AXA Group, through its subsidiaries, provides insurance and asset management services, primarily in Europe, North America and Asia.Axa S.A. 2.4%
ARYZTA AG, formerly IAWS Group plc, is a Switzerland-based company engaged in the manufacture and distribution of specialty bakery products.ARYZTA AG 2.1%
Ashtead Group plc, rents equipment to industrial and commercial users, primarily in the non-residential construction sectors. Ashtead Group plc 2.1%
Britvic plc, together with its subsidiaries, manufactures and distributes soft drinks in the United Kingdom, the Republic of Ireland, and France.Britvic plc 2.1%
ING Groep N.V. (ING) is a global financial institution offering banking, investments, life insurance and retirement services to meet the needs of the customers.ING Groep N.V., Certicaaten Van Aandelen 2.0%
Renault SA designs, manufactures, markets, and repairs passenger cars and light commercial vehicles. The Company also provides financing and service solutions, including credit for new and used vehicles.Renault S.A. 1.9%
Roche Holdings AG is a Switzerland-based pharmaceuticals and diagnostics company.Roche Holdings AG, Genusscheine 1.8%
Marine Harvest ASA, a seafood company, produces and sells farmed salmon products worldwide. It is engaged in the fish farming, processing, and smoking activities.Marine Harvest ASA 1.7%
Bellway p.l.c., through its subsidiaries, is engaged in the house building activities in the United Kingdom. It offers new and second hand homes. The company provides a range of houses, such as detached, semi-detached, terraced, and town houses, as well as apartments and bungalows. Bellway plc 1.7%
Total Portfolio Holdings
(updated quarterly, upon availability)

View | Download (as of 6/30/2014)

Risk Factors: As with any mutual fund, the value of the Fund's shares will change, and you could lose money on your investment. An investment in the Fund is not a bank deposit and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. These and other risks are more fully described in the fund's prospectus. Not all funds or fund classes may be offered at all broker/ dealers.

Pricing: All prices and year-to-date returns are based on closing quotes unless noted, as supplied to the NASDAQ by 6:00 p.m. Eastern time.

Stylebox: The Morningstar Equity style box reveals a fund's investment strategy by displaying the fund's investment style and the market capitalization of the stocks owned.

Index Description: MSCI Europe is an unmanaged index comprised of securities that represent the securities markets in Europe. It is not possible to invest directly in an index.

The MSCI information may only be used for your internal use, may not be reproduced or repurposed in any form and may not be used as a basis for or a component of any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. The MSCI information is provided on an “as is” basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the “MSCI Parties”) expressly disclaims all warranties (including, without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement, salability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages. (www.msci.com) Source: MSCI.

Performance results for some funds may include the effect of expense reduction arrangements. If those arrangements had not been in place, the performance results would have been lower.

A large portion of the fund's since inception return is attributable to investments in initial public offerings, without which the fund's return would have been lower.

Morningstar Ratings: For each fund with at least a 3-year history, Morningstar calculates a risk-adjusted return measure that accounts for variation in a fund's monthly performance (including the effects of all sales charges), placing emphasis on downward variations and rewarding consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. (Each share class is counted as a fraction of one fund and rated separately.) A fund's overall rating is derived from a weighted average of the 3-, 5- and 10-year (if applicable) rating metrics. Morningstar Rating is for the share classes specified; other classes may have different performance characteristics.

Information is subject to change and is not intended to represent any past or future investment recommendations.

Financial Advisor Opportunities
Corporate Careers